Condition
Cephalosporin Allergy
Total Trials
2
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Culprit Cephalosporin Cefazolin Ceftazidime Ceftriaxone Cefepime Cephalexin Cefaclor Cefadroxil Cefuroxime Cefpodoxime Cefdinir Or Cefixime Doubleblind Placebocontrolled Drug Challenge
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Culprit Cephalosporin Cefazolin Ceftazidime Ceftriaxone Cefepime Cephalexin Cefaclor Cefadroxil Cefuroxime Cefpodoxime Cefdinir Or Cefixime Doubleblind Placebocontrolled Drug Challenge1
- Amoxicillin Doubleblind Placebocontrolled Drug Challenge1
- Dissimilar Cephalosporin Ceftriaxone Or Cefazolin Antibiotic Doubleblind Placebocontrolled Drug Challenge1
- Similar Cephalosporin Cefepime Ceftriaxone Cefaclor Cephalexin Cefixime Or Cefdinir Antibiotic Doubleblind Placebocontrolled Drug Challenge1
- Betalactam Antibiotic Cefazolin Cefuroxime Cefotaxime Ceftazidime Ceftriaxone Cefepime Prepen Penicillin G Ampicillin And Histamine Doubleblind Skin Testing1
Active Sponsors
- Chulalongkorn University1
- Massachusetts General Hospital1
- National Institute of Allergy and Infectious Diseases (NIAID)1
Top Investigators
University of Texas Southwestern Medical Center
Mayo Clinic
Chulalongkorn University
Related Conditions
- Druginduced Anaphylaxis1
- Beta Lactam Adverse Reaction1
- Cephalosporin Reaction1
- Drug Allergy1
- Antibiotic Allergy1